| | Webinar: How Providence is Tapping into the Benefits of Patient Activation Tuesday, November 10 | 1pm ET / 10am PT Our healthcare industry has only begun to tap the benefits of patient activation to avoid disruption & improve clinical outcomes, operational efficiency & financial performance. In this session, a panel of experts will review Providence’s My COVID Diary & My Surgical Journey projects & their ability to deliver patient-centric care, & measurable quality, revenue & patient satisfaction improvements. Register Now! |
CureVac links COVID-19 vaccine to immune response, setting it up to enter pivotal trial Why does Walmart think it has a right to play in healthcare? Top health exec Osborne explains Novavax expands in Maryland as it gears up for late-stage COVID vaccine trial in the U.S. As COVID-19 cases surge, Trump suggests he'll fire Fauci after the election Eliquis partners BMS and Pfizer join the pharma crowd urging doctor visits during COVID-19 Biopharma roundup: CureVac shot sparks immune response; Pfizer, BMS launch campaign promoting pandemic doctor visits Need more evidence value-based care is gaining traction? Cerner reports big uptick in interest among providers Hologic nets $119M U.S. government contract to boost coronavirus test manufacturing into 2022 More than half of Americans would use virtual care, UnitedHealth Group survey finds J&J's weekly vaccine series, with 100M views to its credit, finds success demystifying science LabCentral entrepreneurs volunteer for COVID-19 diagnostic trial CMS gives states tools to boost Medicaid home and community-based services Featured Story | By Nick Paul Taylor CureVac has shared phase 1/2 data on its COVID-19 vaccine candidate CVnCoV. The German biotech said the mRNA vaccine dose selected for further development sparked increases in virus-neutralizing antibodies and early indications of T-cell activation. read more |
| |
|---|
|
Top Stories By Paige Minemyer "I think in some ways, it’s not being overly cute or creative. It is about basics but then figuring out ways to do that at more scale," said Walmart Health's chief Marcus Osbourne. Here's what else he had to say about Walmart's approach to healthcare. read more By Eric Sagonowsky Novavax has spent much of 2020 advancing its COVID-19 vaccine candidate through early-stage testing and preparing for manufacturing and distribution. Thanks to the promise of the vaccine and a separate flu program, the company is expanding its Maryland campus. read more By Eric Sagonowsky With just one day left until the 2020 election—and with COVID cases surging—President Donald Trump suggested he’d fire the United States’ top infectious disease doctor, Anthony Fauci. The NIAID chief had told the Washington Post, in an interview published Saturday, that the U.S. is "poorly" positioned to fight the pandemic this winter. read more By Beth Snyder Bulik Pfizer and Bristol Myers Squibb are the latest drugmakers to join the swell of campaigns promoting doctor visits during the pandemic. Focused on three health conditions—atrial fibrillation, deep vein thrombosis and pulmonary embolism, all three treated by the partners' anticoagulant, Eliquis—the awareness push includes TV ads encouraging people to seek prompt medical attention. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner Interim phase 1 data showed CureVac's shot was safe and effective, the company said. Pfizer and BMS want patients to resume doctor visits. J&J's vaccine video series has garnered more than 100 million views since its launch. And LabCentral and BioLabs are teaming up to validate COVID tests patients can use at home. read more By Tina Reed As health IT giant Cerner works with health provider clients to navigate the rocky waters of the COVID-19 pandemic, the company is seeing a big uptick in providers' interest in value-based care, executives said during Cerner's third-quarter earnings call. read more By Conor Hale Hologic has received a $119 million contract from the U.S. government to boost its manufacturing of tests and diagnostic supplies for COVID-19. read more By Tina Reed More than a quarter of respondents said they would prefer a virtual relationship with a primary care physician, a UnitedHealth Group survey found. Here's what else the results show. read more By Beth Snyder Bulik As J&J scientists dove into the novel coronavirus' genetic sequence to assess vaccine candidates, communications exec Seema Kumar was trying to figure out how to let the world know. The answer? A live weekly video series hosted by journalist Lisa Ling. Eight months and more than 100 million views later, it's still going strong. read more By Conor Hale LabCentral has launched a collaborative project to help test and validate quick, simple diagnostics for COVID-19 that people can use to screen themselves at home. read more By Robert King CMS released a toolkit intended to help states shift more long-term care services from nursing homes to home-based care. read more |
